Teva Pharma Stock Forecast - Accumulation Distribution
| TEVA Stock | USD 16.78 0.21 1.27% |
Teva Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Teva Pharma stock prices and determine the direction of Teva Pharma Industries's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Teva Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Teva |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 162874.0 | 131260.0 |
| Check Teva Pharma Volatility | Backtest Teva Pharma | Trend Details |
Teva Pharma Trading Date Momentum
| On November 22 2024 Teva Pharma Industries was traded for 17.12 at the closing time. The top price for the day was 17.13 and the lowest listed price was 16.86 . The trading volume for the day was 7.4 M. The trading history from November 22, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.23% . The trading price change against the current closing price is 3.40% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Teva Pharma to competition |
Other Forecasting Options for Teva Pharma
For every potential investor in Teva, whether a beginner or expert, Teva Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Teva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Teva. Basic forecasting techniques help filter out the noise by identifying Teva Pharma's price trends.Teva Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Teva Pharma Industries Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Teva Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Teva Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Teva Pharma Market Strength Events
Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns.
Teva Pharma Risk Indicators
The analysis of Teva Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Teva Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting teva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.33 | |||
| Standard Deviation | 1.77 | |||
| Variance | 3.14 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out Historical Fundamental Analysis of Teva Pharma to cross-verify your projections. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.85) | Revenue Per Share 14.879 | Quarterly Revenue Growth 0.125 | Return On Assets 0.0556 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.